Pharmnovo Aktiebolag
Developing non-addictive delta opioid receptor agonists for neuropathic pain.
Översikt
- 1–4
- Anställda
- 10–20milj SEK
- Omsättning
- 2007
- Grundat
Nyckelbeslutsfattare
Karin Rosén
Member of the Board
Per von Mentzer
CEO
Olof Breuer
MD, Clinical pharmacology lead
Johan Lund
Chairman and Member of the Board
+2 fler kontakter i Funnelfeedr
Beskrivning
PharmNovo AB is a clinical-phase pharmaceutical company based in Lund, Sweden, focused on addressing the significant unmet medical need in chronic and neuropathic pain management. The company specializes in developing novel compounds based on selective delta opioid receptor agonists (DORAs). Their p...